Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

@article{Wade2004DoCM,
  title={Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients},
  author={D. Wade and P. Makela and P. Robson and H. House and C. Bateman},
  journal={Multiple Sclerosis},
  year={2004},
  volume={10},
  pages={434 - 441}
}
The objective was to determine whether a cannabis-based medicinal extract (CBME) benefits a range of symptoms due to multiple sclerosis (MS). A parallel group, double-blind, randomized, placebo-controlled study was undertaken in three centres, recruiting 160 outpatients with MS experiencing significant problems from at least one of the following: spasticity, spasms, bladder problems, tremor or pain. The interventions were oromucosal sprays of matched placebo, or whole plant CBME containing… Expand
454 Citations

Paper Mentions

Interventional Clinical Trial
A study to compare the efficacy of GW-1000-02 [named Sativex® in Canada and also named Sativex® Oromucosal Spray] with placebo in relieving five key symptoms of Multiple Sclerosis… Expand
ConditionsMultiple Sclerosis
InterventionDrug
Interventional Clinical Trial
An open-label extension study in which patients with multiple sclerosis received GW-1000-02 [named Sativex® in Canada and also named Sativex® Oromucosal Spray] for four weeks in an… Expand
ConditionsMultiple Sclerosis
InterventionDrug
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
  • 248
  • PDF
4 Drugs of abuse
  • 1
The therapeutic value of cannabinoids in MS: real or imaginary?
  • 12
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
...
1
2
3
4
5
...